Maze Therapeutics (MAZE) Non-Current Assets (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Non-Current Assets data on file, last reported at $39.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets rose 20.52% year-over-year to $39.9 million; the trailing twelve-month figure through Mar 2026 stood at $150.5 million (changed N/A YoY), and the FY2025 full-year result was $47.4 million, up 21.97% from the prior year.
• Non-Current Assets retreated to $39.9 million in Q1 2026, from $47.4 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $47.4 million in Q4 2025 to a low of $30.8 million in Q3 2025.
• A 3-year average of $37.1 million and a median of $36.0 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets advanced 21.97% in 2025 and advanced 20.52% in 2026, its largest moves.
• Tracing MAZE's Non-Current Assets over 3 years: stood at $38.9 million in 2024, then grew by 21.97% to $47.4 million in 2025, then decreased by 15.78% to $39.9 million in 2026.
• Business Quant data shows MAZE's Non-Current Assets at $39.9 million in Q1 2026, $47.4 million in Q4 2025, and $30.8 million in Q3 2025.